Multiple Myeloma

GSK mulls filings for multiple myeloma drug
Pharmaforum
Fri, 03/22/19 - 10:06 am
GSK
GSK2857916
antibody-drug conjugate
Multiple Myeloma
AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a treatment for multiple myeloma
Marketwatch
Tue, 03/19/19 - 10:36 am
AbbVie
venetoclax
Multiple Myeloma
FDA
clinical trials
Karyopharm gets bump as FDA extends review of selinexor
BioCentury
Fri, 03/15/19 - 10:42 am
Karyopharm
FDA
Selinexor
Multiple Myeloma
J&J Seeks Approval for Darzalex in Expanded Patient Group
Yahoo/Zacks.com
Fri, 03/15/19 - 09:16 am
JNJ
Darzalex
Multiple Myeloma
FDA
U.S. court rejects Alvogen's patent challenge for Celgene's cancer drug
Yahoo/Reuters
Thu, 03/14/19 - 10:18 am
Celgene
Revlimid
patents
Multiple Myeloma
Alvogen
Karyopharm down as FDA reviewers cast doubt on selinexor's benefit
BioCentury
Sat, 02/23/19 - 04:35 pm
Karyopharm Therapeutics
FDA
Selinexor
Multiple Myeloma
Celgene's Revlimid defenses withstand another challenge
Biopharma Dive
Tue, 02/12/19 - 10:14 am
Celgene
Revlimid
Multiple Myeloma
Dr Reddy's
patents
AbbVie gains option to Teneobio BCMA program
BioCentury
Mon, 02/11/19 - 08:04 pm
AbbVie
Teneobio
TNB-383B
Multiple Myeloma
Gilead drops anti-BCMA CAR-T from Kite, takes $820M charge
Fierce Biotech
Tue, 02/5/19 - 11:50 am
Gilead Sciences
Multiple Myeloma
Kite Pharma
anti-BCMA
Sanofi's isatuximab meets survival endpoint for third-line multiple myeloma
BioCentury
Tue, 02/5/19 - 10:09 am
Sanofi
FDA
EMA
isatuximab
relapsed or refractory multiple myeloma
Multiple Myeloma
Genmab's blockbuster Darzalex surpasses $2B in sales
BioCentury
Tue, 01/8/19 - 11:40 pm
Genmab
Multiple Myeloma
Darzalex
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
Mon, 12/10/18 - 07:07 pm
clinical trials
Multiple Myeloma
adaptive trial design
AbbVie
Celgene
Eli Lilly
Genentech
Janssen
Takeda
ASH: J&J's fast-growing Darzalex lines up for second front-line myeloma OK
Fierce Pharma
Tue, 12/4/18 - 11:33 am
JNJ
Darzalex
Multiple Myeloma
ASH 2018
Weekend ASH presentations hint at future of BCMA CARs
BioCentury
Tue, 12/4/18 - 09:39 am
ASH 2018
BCMA
CAR-T
Multiple Myeloma
ASH18: Legend's CAR-T brought back to reality
Biopharma Dive
Mon, 12/3/18 - 10:53 pm
Legend Biotech
ASH 2018
CAR-T
Multiple Myeloma
ASH: Takeda maintenance data sets up Ninlaro for new myeloma nod
Fierce Pharma
Sun, 12/2/18 - 12:34 pm
ASH2018
Takeda
Ninlaro
Multiple Myeloma
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Fierce Pharma
Thu, 11/8/18 - 09:41 am
Bristol-Myers Squibb
AbbVie
Empliciti
FDA
Multiple Myeloma
Celgene
Pomalyst
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
CP Wire
Tue, 11/6/18 - 09:31 am
Fortis Therapeutics
prostate cancer
Multiple Myeloma
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
Tue, 11/6/18 - 09:23 am
Fortis Therapeutics
prostate cancer
Multiple Myeloma

Pages